Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Aquestive Therapeutics, Inc. (AQST) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Investor presentation, Quarterly results
Docs: "Exhibit 99.1 Aquestive Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update"
03/07/2023 8-K Investor presentation, Quarterly results
Docs: "Aquestive Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Business Update on Key 2023 Objectives",
"2022 14.7 17.7 18.6 27.3 0 5 10 15 20 25 30"
08/02/2022 8-K Quarterly results
Docs: "Aquestive Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update"
05/03/2022 8-K Quarterly results
Docs: "Aquestive Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update"
03/08/2022 8-K Quarterly results
11/02/2021 8-K Quarterly results
Docs: "Aquestive Therapeutics Reports Third Quarter 2021 Financial Results, Provides Business Update and Improves Full Year Guidance"
08/03/2021 8-K Quarterly results
Docs: "Aquestive Therapeutics Reports Second Quarter 2021 Financial Results, Provides Business Update and Raises Full Year Revenue Guidance"
03/09/2021 8-K Quarterly results
11/04/2020 8-K Quarterly results
Docs: "Aquestive Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update"
08/04/2020 8-K Quarterly results
05/05/2020 8-K Quarterly results
Docs: "Update: AQST-108 and Libervant Remain On Track"
03/11/2020 8-K Quarterly results
11/05/2019 8-K Quarterly results
08/06/2019 8-K Quarterly results
05/08/2019 8-K Quarterly results
Docs: "Press Release, announcing financial results for the quarter ended March 31, 2019"
03/14/2019 8-K Quarterly results
Docs: "Aquestive Therapeutics, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights"
11/06/2018 8-K Quarterly results
Docs: "Aquestive Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Highlights",
"Aquestive Therapeutics Announces U.S. Food and Drug Administration Approval for SYMPAZAN TM Oral Film"
09/04/2018 8-K Quarterly results
Docs: "Aquestive Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Highlights, Including Tentative Approval for Sympazan TM",
"Aquestive Therapeutics Announces Tentative FDA Approval for Sympazan TM Oral Film"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy